130 related articles for article (PubMed ID: 21934670)
1. Damage control: how HIV survives the editor APOBEC3G.
Croxford JL; Gasser S
Nat Immunol; 2011 Sep; 12(10):925-7. PubMed ID: 21934670
[TBL] [Abstract][Full Text] [Related]
2. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.
Norman JM; Mashiba M; McNamara LA; Onafuwa-Nuga A; Chiari-Fort E; Shen W; Collins KL
Nat Immunol; 2011 Aug; 12(10):975-83. PubMed ID: 21874023
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus.
Rose KM; Marin M; Kozak SL; Kabat D
J Biol Chem; 2004 Oct; 279(40):41744-9. PubMed ID: 15297452
[TBL] [Abstract][Full Text] [Related]
4. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
Romani B; Engelbrecht S; Glashoff RH
Arch Virol; 2009; 154(10):1579-88. PubMed ID: 19669862
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.
Pery E; Sheehy A; Nebane NM; Brazier AJ; Misra V; Rajendran KS; Buhrlage SJ; Mankowski MK; Rasmussen L; White EL; Ptak RG; Gabuzda D
J Biol Chem; 2015 Apr; 290(16):10504-17. PubMed ID: 25724652
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity in resistance to HIV infection.
Biasin M; Clerici M; Piacentini L
J Infect Dis; 2010 Nov; 202 Suppl 3():S361-5. PubMed ID: 20887225
[TBL] [Abstract][Full Text] [Related]
7. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.
Ward J; Davis Z; DeHart J; Zimmerman E; Bosque A; Brunetta E; Mavilio D; Planelles V; Barker E
PLoS Pathog; 2009 Oct; 5(10):e1000613. PubMed ID: 19798433
[TBL] [Abstract][Full Text] [Related]
9. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 70 inhibits HIV-1 Vif-mediated ubiquitination and degradation of APOBEC3G.
Sugiyama R; Nishitsuji H; Furukawa A; Katahira M; Habu Y; Takeuchi H; Ryo A; Takaku H
J Biol Chem; 2011 Mar; 286(12):10051-7. PubMed ID: 21228271
[TBL] [Abstract][Full Text] [Related]
11. Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.
Nagao T; Yamashita T; Miyake A; Uchiyama T; Nomaguchi M; Adachi A
J Med Invest; 2010 Feb; 57(1-2):89-94. PubMed ID: 20299747
[TBL] [Abstract][Full Text] [Related]
12. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
Mehle A; Strack B; Ancuta P; Zhang C; McPike M; Gabuzda D
J Biol Chem; 2004 Feb; 279(9):7792-8. PubMed ID: 14672928
[TBL] [Abstract][Full Text] [Related]
13. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent.
Browne EP; Allers C; Landau NR
Virology; 2009 May; 387(2):313-21. PubMed ID: 19304304
[TBL] [Abstract][Full Text] [Related]
14. The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway.
Zhou D; Wang Y; Tokunaga K; Huang F; Sun B; Yang R
Virus Res; 2015 Jan; 195():25-34. PubMed ID: 25200749
[TBL] [Abstract][Full Text] [Related]
15. Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif.
Shao Q; Wang Y; Hildreth JE; Liu B
J Virol; 2010 May; 84(9):4840-4. PubMed ID: 20147392
[TBL] [Abstract][Full Text] [Related]
16. Vif and Apobec3G in the innate immune response to HIV: a tale of two proteins.
Farrow MA; Sheehy AM
Future Microbiol; 2008 Apr; 3(2):145-54. PubMed ID: 18366335
[TBL] [Abstract][Full Text] [Related]
17. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.
Conticello SG; Harris RS; Neuberger MS
Curr Biol; 2003 Nov; 13(22):2009-13. PubMed ID: 14614829
[TBL] [Abstract][Full Text] [Related]
18. Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors.
Gandhi SK; Siliciano JD; Bailey JR; Siliciano RF; Blankson JN
J Virol; 2008 Mar; 82(6):3125-30. PubMed ID: 18077705
[TBL] [Abstract][Full Text] [Related]
19. [Enhanced protein production of Vif and APOBEC3G by HIV-1 Vpr].
Li L; Liang D; Li JY; Zhao YQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):39-41. PubMed ID: 18414697
[TBL] [Abstract][Full Text] [Related]
20. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.
Newman EN; Holmes RK; Craig HM; Klein KC; Lingappa JR; Malim MH; Sheehy AM
Curr Biol; 2005 Jan; 15(2):166-70. PubMed ID: 15668174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
